Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sto M Tab. in Patients With Acute or Chronic Gastritis
NCT07631065Phase 4Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Feb 2028
01
Overview
Phase 4, randomised, double-blind trial in acute gastritis and chronic gastritis (2 arms). Primary endpoint: Effective Rate of Gastric Mucosal Erosion Assessed by an Independent Reviewer at Week 2. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
acute gastritischronic gastritis
Beyond the preview
Go deeper on NCT07631065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07631065.